Key Segmentation
By Treatment Type
-
Surgery
-
Radiation Therapy
-
Chemotherapy
-
Targeted Therapy
-
Immunotherapy
-
Others
By Tumor Type
-
Glioblastoma
-
Astrocytoma
-
Medulloblastoma
-
Meningioma
-
Pituitary Tumors
-
Others
By Drug Class
-
Alkylating Agents
-
Targeted Therapy Drugs
-
Immunotherapy Drugs
-
Antimetabolites
-
Others
By End User
-
Hospitals
-
Specialty Clinics
-
Research Centres
By Distribution Channel
-
Hospital Pharmacies
-
Retail Pharmacies
-
Online Pharmacies
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market player
Frequently Asked Questions
North America dominated with approximately 40.85% of revenues in 2025.
Surgery dominated with approximately 35.42% of revenues in 2025.
Rising global brain tumor incidence with population ageing combined with expanding precision medicine targeted therapy options for molecularly defined tumor subgroups and immunotherapy clinical progress driving treatment landscape evolution toward personalized neuro-oncology.
The Brain Tumor Treatment Market was valued at USD 3.55 billion in 2025.
The Brain Tumor Treatment Market is expected to grow at a CAGR of 7.29% from 2026 to 2035.